Recently published studies assert that Ozempic significantly increases the risk of developing a rare eye condition called non ...
The European Union’s drug regulator said it would review two studies that link Novo Nordisk’s blockbuster diabetes drug ...
With U.S. headquarters in Plainsboro, Novo Nordisk told NJBIZ, "NAION is a very rare eye disease, and it is not an adverse ...
Danish studies have found a potential link between the diabetes drug Ozempic and a rare eye condition called non-arteritic ...
Following an appeal by the Danish Medicines Agency, the European Union’s drug regulator will review two new studies that have ...
Several recent studies have found a possible connection between semaglutide use and a rare condition that causes sudden ...
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated ...
The European Union's drug regulator said it would assess two new Danish studies that link Novo Nordisk's popular diabetes ...
A vision-threatening eye condition may be linked to Ozempic. Meanwhile, Nearly 80% of doctors are using telemedicine weekly, ...
GLP weight-loss drug Ozempic has reportedly been linked to a rare form of vision loss, known as non-arteritic anterior ischemic optic neuropathy (NAION). The study, which has yet to be peer-reviewed, ...
Denmark's drug regulator asks EMA to investigate potential link between Novo Nordisk's diabetes drug Ozempic and rare eye ...
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the ...